Telecommunication Services

NextPlat

NextPlat released FY2026 Q1 earnings on May 14 Pre-Market (EST), actual revenue USD 9.855 M, actual EPS USD -0.42

NextPlat to Release FY2026 Q1 Earnings on May 14, Pre-Market EST

NextPlat released FY2025 Annual Earnings on March 31 Pre-Market (EST), actual revenue USD 54.32 M, actual EPS USD -0.4413

NextPlat released FY2025 Q4 earnings on March 31 Pre-Market (EST), actual revenue USD 12.81 M, actual EPS USD -2.2966

NextPlat to Release FY2025 Earnings Report on March 31, Pre-Market EST

NextPlat Corp Projects 75% Quarterly Revenue Growth

NextPlat released FY2025 Q3 earnings on November 13 Pre-Market (EST), actual revenue USD 13.75M, actual EPS USD -0.8406

NextPlat released FY2025 9 Months Earnings on November 13 Pre-Market EST, with actual revenue of USD 41.52 M and EPS of USD -0.2057

NextPlat FY2025 Q3 Earnings Release on November 13, 2025 Pre-Market EST

NextPlat released FY2025 Q2 earnings on August 14 Pre-Market (EST), actual revenue USD 13.24 M, actual EPS USD -0.7

NextPlat released FY2025 Semi-Annual earnings on August 14 Pre-Market (EST), actual revenue USD 27.77 M, actual EPS USD -1.2063

NextPlat to Release FY2025 Q2 Earnings Report on August 14, Pre-Market EST

NextPlat Holds Annual Meeting to Approve Seven Directors Election

NextPlat's Subsidiary Becomes ZOLEO's Exclusive Distributor in UK and Europe

NextPlat released FY2025 Q1 earnings on May 15 Pre-Market EST, actual revenue USD 14.53 M, actual EPS USD -0.5172

NextPlat to Release FY2025 Q1 Earnings Report on May 15, Pre-Market EST

NextPlat Receives Nasdaq Notice on Stock Price Issues

NextPlat Suspends E-Commerce Initiatives Due to Tariff Impact

NextPlat released FY2024 Annual Earnings on March 24 Pre-Market (EST), actual revenue USD 66.08 M, actual EPS USD -0.6513

NextPlat released FY2024 Q4 earnings on March 24 Pre-Market EST, actual revenue USD 16.23 M, actual EPS USD -0.9526

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

NXPL

Earnings Watch

NextPlat | 8-K: FY2026 Q1 Revenue: USD 9.855 M

NextPlat (NASDAQ:NXPL) reported its Q1 2026 financial results, highlighting significant margin expansion and improved profitability, primarily from its healthcare operations, which contributed 68% of revenue. The company regained compliance with NASDAQ's minimum bid requirement after a reverse stock split. Gross margin increased to 35% from 21% year-over-year, driven by higher-margin revenue streams. NextPlat ended the quarter with $11 million in cash and no significant debt, focusing on sustaining profitability and exploring growth through potential joint ventures or acquisitions.

benzinga_article

SPDR Pharmac

iShares US Pharma

VanEck Pharmaceutical ETF

Invesco Pharmaceuticals ETF

VG Health

SPDR S&P Health

Health Care Select Sector SPDR

NEXTPLAT CORP C/WTS 02/06/2026 (TO PUR COM)

NextPlat Reports Q1 2026 Results: Full Earnings Call Transcript

NextPlat Corp reported $9.9 million in revenue for Q1 2026, a 29% decrease from the previous year, primarily due to lower healthcare revenue. However, the company achieved a record gross margin of 35%, up from 21% year-over-year, driven by improved pharmacy operations and new contracts. Operating expenses decreased by 9% to $4.5 million, reflecting ongoing cost-cutting measures. The CEO expressed optimism about future growth and profitability, anticipating positive income from operations in the latter half of 2026 as the company continues its turnaround efforts.

prnewswire

08:01 ETNextPlat Reports $9.9 Million in Revenue for Q1 2026 with Record Quarterly Consolidated Gross Margins of 35%

NextPlat Expects Q1 2026 Gross Margins to Jump to 34+%, Operating Expenses to Decline 8+% From Q4 2025 and Achieve Positive Operating Income in Q3 | NXPL Stock News

StockTitan

NextPlat Expects Q1 2026 Gross Margins to Jump to 34+%, Operating Expenses to Decline 8+% From Q4 2025 and Achieve Positive Operating Income in Q3 | NXPL Stock News

ONLN

EBIZ

NextPlat Corp has regained compliance with Nasdaq's minimum bid price requirement, stabilizing its listing status after trading below $1.00 for 30 consecutive days. The stock traded above $1.00 for 10 consecutive days, affirming its listing on the Nasdaq Capital Market under ticker NXPL. Despite this, Spark's AI Analyst rates NXPL as Neutral due to ongoing financial losses and declining revenue, although technical indicators remain supportive. NextPlat operates in healthcare and technology solutions through e-commerce and retail channels, with a current market cap of $17.94M.

Tip Ranks

ProShares Online Retail

VanEck Retail ETF

SPDR S&P Retail ETF

Global X E-commerce ETF

Amplify Online Retail ETF

Nasdaq

NextPlat Regains Nasdaq Compliance, Stabilizing Listing Status

NextPlat Corp has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, as confirmed by a Compliance Letter received on April 27, 2026. The company's shares have maintained a closing bid price of $1.00 or greater for the last 10 consecutive business days, allowing it to remain listed on The Nasdaq Capital Market under the ticker symbol "NXPL."

08:01 ETNextPlat Regains Compliance with Nasdaq Bid Price Requirement

NextPlat's PharmcoRx Deploys Artificial Intelligence-Powered Prescription Processing Technology Supporting Expanded Nationwide Fulfillment Efforts | NXPL Stock News

NextPlat's PharmcoRx Deploys Artificial Intelligence-Powered Prescription Processing Technology Supporting Expanded Nationwide Fulfillment Efforts | NXPL Stock News

NextPlat(NXPL.US)

NextPlat | 8-K: FY2026 Q1 Revenue: USD 9.855 M

NextPlat Reports Q1 2026 Results: Full Earnings Call Transcript

08:01 ETNextPlat Reports $9.9 Million in Revenue for Q1 2026 with Record Quarterly Consolidated Gross Margins of 35%

NextPlat Expects Q1 2026 Gross Margins to Jump to 34+%, Operating Expenses to Decline 8+% From Q4 2025 and Achieve Positive Operating Income in Q3 | NXPL Stock News

NextPlat Regains Nasdaq Compliance, Stabilizing Listing Status

08:01 ETNextPlat Regains Compliance with Nasdaq Bid Price Requirement

NextPlat's PharmcoRx Deploys Artificial Intelligence-Powered Prescription Processing Technology Supporting Expanded Nationwide Fulfillment Efforts | NXPL Stock News